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Abstract
The degree of fat deposition in muscle and
its  implications  for  obesity-related  complica-
tions  in  children  and  youths  are  not  well
understood.  One  hundred  and  fifty-nine
patients (mean age: 13.3 years; range: 6-20)
with a body mass index (BMI) >90th percentile
for age and sex were included. Muscle fat con-
tent (MFC) was measured in the psoas muscle
by  proton  magnetic  resonance  spectroscopy.
The patients were assigned to two groups: MFC
<5% or ≥5%. Visceral adipose tissue volume
(VAT)  and  subcutaneous  adipose  tissue  vol-
ume (SAT) were measured by magnetic reso-
nance  imaging.  The  data  were  analysed  to
detect  associations  between  MFC  and  BMI
standard deviation scores, VAT and SAT, blood
values, pubertal stages, and physical activity
scores.  The  mean  BMI  standard  deviation
score (SDS) was 3.04 (range 1.32-5.02). The
mean MFC was 8.9% (range 0.8-46.7), and 118
(74.2%)  of  159  patients  had  an  MFC  ≥5%.
Children  with  an  MFC  ≥5%,  compared  with
children with an MFC <5%, had a higher BMI
SDS (P=0.03), a higher VAT (P=0.04), and ele-
vated  intramyocellular  lipid  (IMCL)  and
extramyocellular lipid (EMCL) contents (both
P<0.0001). SAT, SAT/VAT ratio, blood values,
pubertal stages and physical activity scores did
not  differ  between  the  two  groups.  Severely
obese children and youths tend to have a high
MFC, which is associated with elevated VAT,
IMCL, and EMCL contents. An increased MFC
may  be  associated  with  impaired  metabolic
processes, which may predispose these young
people to obesity-related complications.
Introduction
Obesity is strongly associated with the inci-
dence  of  cardiovascular  disease,  diabetes,
fatty liver disease, and cancer.1 Decades ago,
it became evident that ectopic fat deposition is
an important predictor of cardiovascular dis-
ease and carries more risk than ordinary fat
accumulation in subcutaneous fat deposits.2,3
The ectopic fat deposition in non-adipose tis-
sue, including skeletal muscle, has deleteri-
ous effects including tissue damage (lipotoxi-
city) and the development of insulin resist-
ance (IR).4 The cause of ectopic fat distribu-
tion seems to be related to the hyperlipolytic
activity of the visceral adipose tissue, which
induces  a  lipotoxic  state  and  contributes  to
the exposure to excess free fatty acids. Excess
fat distribution and exposure to excess free
fatty acid impair insulin-dependent metabolic
processes and lead to biochemical abnormali-
ties, including hyperinsulinaemia and hyper-
triglyceridaemia.5
Muscle fat content (MFC) has been quanti-
fied using methods such as computer tomogra-
phy  scanning6,7 and  biochemical  extraction,8
which do not distinguish between intramyocel-
lular  lipid  (IMCL)  and  extramyocellular  lipid
(EMCL).  These  studies  showed  that  a  high
MFC is associated with IR in non-diabetic indi-
viduals,7,8 in people with type 2 diabetes melli-
tus9,10 or poorly controlled type 1 diabetes,9 in
older people,11 and in patients with coronary
artery  disease.12 The  development  of  proton
magnetic  resonance  spectroscopy  (MRS)
allows the non-invasive and non-ionizing dif-
ferentiation and quantification of lipid deposits
in skeletal muscle and can distinguish between
IMCL and EMCL.13,14 This technology is antici-
pated to further our understanding of lipid dep-
osition in muscle and its association with com-
plications related to obesity.
In the present study, the content of muscu-
lar  fat  was  investigated  by  MRS  in  a  large
group of obese children and youths referred for
childhood obesity treatment.15 The hypothesis
to be tested was whether the degree of fat in
muscles was associated with general or central
obesity and/or physical activity/inactivity. The
participants  were  assigned  to  two  groups
based on the fat content in their psoas muscle:
MFC <5% or ≥5%. The objective of this study
was  to  quantify  the  MFC  percentage  and  to
investigate possible associations with anthro-
pometric data, visceral adipose tissue volume
(VAT),  subcutaneous  adipose  tissue  volume
(SAT),  biochemical  measurements,  pubertal
stage, physical activity score (PAS), and physi-
cal inactivity score (PIS).
Materials and Methods
Study population
One hundred and ninety-two obese children
and youths were enrolled consecutively from
August 2009 to August 2010 at The Children’s
Obesity  Clinic,  Department  of  Paediatrics,
Copenhagen  University  Hospital,  Holbæk,
Denmark.15 The inclusion criteria were 6-20
years  of  age  and  a  body  mass  index  (BMI)
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>90th percentile by age- and sex-adjusted ref-
erence  tables.16 The  exclusion  criteria  were
inability to remain calm in the magnetic reso-
nance (MR) scanner for 45 minutes or a body
weight  >130  kg,  which  was  the  maximum
capacity  for  the  MR  scanner.  Eight  patients
had a body weight >130 kg and where thus not
offered an MR scan. Twenty-seven patients did
not  attend  their  planned  MR  examination,
leaving 159 patients for the study.
To elucidate the differences between those
with a relatively low MFC and those with a rel-
atively high MFC, the study sample was divid-
ed in two groups according to the amount of
MFC. These groups were arbitrarily defined as:
MFC <5% and MFC ≥5%. This limit was chosen
because a 5% limit for ectopic fat deposition is
also used to study non-alcoholic fatty liver dis-
ease17 and since there is no widely accepted
limit of fat content in muscles. 
All participants underwent a complete phys-
ical examination and provided a detailed med-
ical history, including interview-reported infor-
mation on physical activity and inactivity. The
PAS included organized sports (soccer, tennis,
dance, etc.) and unorganized activities (tram-
poline,  walking,  cycling,  etc.).  The  PAS  was
defined as the number of hours spent perform-
ing  physical  activities  and  was  summed  to
obtain  the  number  of  hours  per  week.  The
activities  being  a  scout,  unorganized  play,
unorganized walking, and bowling were con-
sidered to represent a lower physical activity
level  than  traditional  organized  sports.  The
reported estimated time spent on these partic-
ular activities was thus reduced by 50% in the
calculation of PAS. The PIS was defined as the
number of hours spent in front of a computer,
television, or game console and was summed
to obtain the number of hours per week. The
activity scores were calculated to test whether
the least physical active exhibited the highest
content of muscular fat.
Blood samples were available in 119 of the
159 individuals and were acquired within 122
days from the date of the MR scan. Informed
written consent was obtained from the parents
of children younger than 18 years and from
patients 18 years of age and older. The study
was approved by the Ethics Committee of the
Region Zealand in Denmark (ID no.: SJ-98 and
SJ-104)  and  the  Danish  Data  Protection
Agency, and is registered at ClinicalTrials.gov
(ID no.: NCT00823277 and NCT00928473).
Anthropometry
Weight was measured to the nearest 0.1 kg
on a Tanita digital medical scale (WB-100 MA;
Tanita Corp., Tokyo, Japan). Height was meas-
ured  by  stadiometer  to  the  nearest  1  mm.
Weight  and  height  were  measured  in  light
indoor clothes with empty pockets and without
shoes.  BMI  was  calculated  as  weight/height
squared (kg/m2). The BMI standard deviation
score (SDS) was calculated by the least-mean-
squares method by converting BMI into a nor-
mal  distribution  by  sex  and  age  using  the
median, coefficient of variation, and a meas-
ure  of  the  skewness  based  on  the  Box  Cox
power  plot  based  on  Danish  BMI  charts.16
Tanner  stage  (development  of  genitals  and
pubic hair in boys and development of breasts
and  pubic  hair  in  girls)  and  testicular  size
were determined by a paediatrician according
to accepted criteria.18
Magnetic resonance spectroscopy
and magnetic resonance imaging 
MR measurements were performed on an
Achieva  3.0  T  MR  imaging  system  (Philips
Medical  Systems,  Best,  The  Netherlands)
using  a  SENSE  cardiac  coil.  Patients  were
examined in the supine position.
The  MFC  and  the  EMCL/IMCL  ratio  were
measured by MRS. IMCL and EMCL were calcu-
lated  using  the  values  of  MFC  and  the
EMCL/IMCL ratio; MFC equals the sum of the
IMCL and EMCL. T2-weighted turbo spin echo
(TSE)  coronal  and  axial  slices  through  the
abdomen were acquired to position the spec-
troscopy  volumes  of  interest  (VOIs).  The
parameters for the TSE sequence were: TSE
factor=93, repetition time (TR)=2182 ms, echo
time (TE)=80 ms, and field of view (FOV)=420
mm. The spectroscopy VOI (11 mm×11 mm×11
mm) was positioned within the psoas muscle.
To obtain the spectroscopic MFC, a single voxel
spectrum  was  recorded  using  the  PRESS
sequence with TE=75 ms, TR=4000 ms, and 32
averages. The MR scanner’s software was used
to fit the acquired spectrum to the relative con-
tent  of  water  and  fat.  To  determine  the
EMCL/IMCL ratio, a single voxel spectrum was
recorded using the PRESS sequence with water
saturation,  TE=38  ms,  TR=4000  ms,  and  80
averages in the same VOI. Spectroscopic MFC
was expressed as fat content relative to water
and  was  calculated  as:  spectroscopic  fat
(%)=(fat  metabolite  area/(fat  metabolite
area+water  metabolite  area))×100%.  The
IMCL% expresses the volume fraction of lipid
droplets within the myocyte cytoplasm as a per-
centage  of  the  total  muscle  volume.  The
EMCL%  expresses  the  fraction  of  adipocytes
interlaced between the muscle fibres as a per-
centage of the total muscle volume.
VAT  and  SAT  volumes  were  measured  by
MRI. A fast T1-weighted turbo field echo (TFE)
MR sequence in the transverse plane was used
to obtain images for estimating the adipose
tissue  volumes  (TFE  sequence,  TFE  fac-
tor=136, TR=10 ms, TE=2.3 ms, FOV=480 mm,
and a respiratory trigger compensation with
trigger delay of 1000 ms). A transverse slice of
10 mm thickness was acquired for all subjects
in the middle of the third lumbar vertebra (L3).
The volumes of visceral and subcutaneous fat
at L3 were measured in cm3 using segmenta-
tion  tool in  volume  analysis on  the  Philips
ViewForum workstation.
Blood sampling
Blood  samples  were  drawn  intravenously
from an antecubital vein after 12 hours of fast-
ing.  If  required,  an  anaesthetic  cream  was
applied 60 min before venepuncture. The bio-
chemical  analyses  were  performed  on  a
Cobas® 6000  analyser  (Roche  Diagnostics,
Rotkreuz, Switzerland) immediately after the
blood samples were obtained. Measurements
included  the  concentrations  of  triglycerides
(TGs),  gamma-glutamyl  transferase  (GGT),
alanine transaminase (ALT), lactate dehydro-
genase (LDH), and alkaline phosphatase (AP). 
Statistical analysis
The two groups of MFC (below 5% and above
5%,  respectively)  were  analysed  according  to
associations with age, BMI SDS, MFC, IMCL,
EMCL,  EMCL/IMCL  ratio,  SAT,  VAT,  SAT/VAT
ratio,  PAS,  PIS,  blood  values,  and  pubertal
stages using ttests. Values of SAT, VAT, pubertal
stages, PAS, PIS, and concentrations of TG, GGT,
ALT, LDH, and AP had non-normally distributed
residuals and were logarithmically transformed
prior to statistical analysis. The results are pre-
sented as means with SD and medians with
ranges, respectively. Further, we divided each
group of MFC into boys and girls and repeated
the  analyses.  By  chi-square  test  we  analysed
associations between MFC and BMI SDS, asso-
ciations between IMCL and EMCL and TG con-
centration,  the  differences  in  MFC  between
sexes, and pubertal stage by menarche for the
girls. Logistic regression analysis was used to
investigate the associations between MFC and
the degree of obesity, SAT, and VAT. P<0.05 were
considered  significant.  Analyses  were  per-
formed using SAS® (version 9.2; SAS Institute
Inc., Cary, NC).
Results
The baseline characteristics of the included
obese children and youths are summarized in
Table 1. The mean MFC in 159 children and
youths  was  8.9%  (range:  0.8%-46.7%).  One
hundred and eighteen patients (74.2%), com-
prising 51 boys and 67 girls, had an MFC ≥5%.
Compared with the group with an MFC <5%,
the group with an MFC ≥5% had a higher BMI
SDS (3.1±0.5 (SD) vs. 2.8±0.7, P=0.03) and
higher VAT (median 94 cm3, range: 30-258 vs.
median 83 cm3, range: 36-186, P=0.04) (Table
1). The two groups did not differ on sex distri-
bution  (P=0.54),  age  (mean  13.2  years±3.0,
range:  6-20  vs. 13.5  years±2.6,  range:  8-18;
P=0.51),  SAT  (P=0.12),  SAT/VAT  ratio
(P=0.47), pubertal stages ((Tanner; 0.17≤ P≤
0.94), left testicle size (median 4 mL, range: 1-
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19 vs. 5 mL, range: 2-20, P=0.18), or right testi-
cle size (median 3 mL, range: 1-18 vs. 5 mL,
range: 2-20, P=0.09), and menarche (P=0.24)).
The regression analyses between MFC and BMI
SDS, VAT, and SAT, respectively, are shown in
Figure 1. 
The mean IMCL% was 3.1%±2.0 in patients
with an MFC ≥5% and 1.4%±0.8 in those with
an MFC <5% (P<0.0001); the respective values
for mean EMCL% were 7.8%±6.3 vs. 1.9%±0.9,
(P<0.0001)  and  the  EMCL/IMCL  ratios  were
3.2±2.8 vs. 2.1±1.7 (P=0.003) (Table 1). The
mean MFC among the 159 participants did not
differ  significantly  between  boys  and  girls
(7.9%±5.4%  vs. 9.5%±7.7%,  respectively,
P=0.28) (Table 1).
PAS was a median of 1.0 hours/week (range
0.0-8.0)  and  this  did  not  differ  significantly
between the groups with MFC <5% and ≥5%,
respectively,  (P=0.47)  (Table  1).  PIS  was  a
median of 24.5 hours/week (range 3.5-70) and
this  did  not  differ  significantly  between  the
groups with MFC <5% and ≥5%, respectively,
(P=0.08) (Table 1).
Blood values were distributed uniformly in
the two MFC groups (Table 2). There were no
differences in mean MFC (P=0.08), BMI SDS
(P=0.35),  or  age  (P=0.07)  between  the  119
patients with MRS, anthropometric, and bio-
chemical measurements and the 40 patients
who were investigated by MRS and anthropo-
metric  measurements  alone.  We  found  no
associations  between  the  TG  concentration
and IMCL content (P=0.71) or between the TG
concentration and EMCL content (P=0.82). All
blood samples were attempted to be performed
in  close  proximity  to  treatment  initiation
(median 9 days, range: 0-170). Blood samples
were acquired a median of 41 days (range: 0-
122)  from  the  MR  examination.  Ninety-six
blood samples were acquired before the MR
examination,  and  17  blood  samples  were
acquired after the MR examination.
Discussion
In the present study, MR spectroscopy was
used to non-invasively quantify the intra- and
extramyocellular  lipid  content  in  159  obese
children and youths included in a multidisci-
plinary obesity treatment.15 We found that a
substantial  proportion  (74.2%)  of  these
patients had an MFC of ≥5%. A high MFC was
correlated with a higher BMI SDS and a high-
er VAT, but not with sex, age, SAT, SAT/VAT-
ratio,  pubertal  stage,  testicular  size,  menar-
che, PAS, PIS, or biochemical measures includ-
ing liver enzymes. As expected, the MFC was
strongly associated with both IMCL and EMCL.
The IMCL was twice as high and the EMCL four
times higher in patients with a high MFC com-
pared with those with an MFC <5%, suggesting
Article
Figure 1. Regression analyses between MFC and BMI SDS, VAT, and SAT in 159 children
and youths included in the study. A) Linear regression analysis plot of MFC and BMI
SDS with Pearson’s correlation coefficient (r2=0.040, 95% CI=[-0.116; 0.194], P=0.012).
Equation: y=2.32x+1.90, effect size=2.32, 95% CI=[0.52; 4.12]. B) Linear regression
analysis plot of MFC and BMI SDS with Pearson’s correlation coefficient (r2=0.039, 95%
CI=[-0.117; 0.193], P=0.013). Equation: y=0.03x+5.92, effect size=0.03, 95% CI=[0.01;
0.06]. C) Linear regression analysis plot of MFC and BMI SDS with Pearson’s correlation
coefficient (r2=0.029, 95% CI=[-0.127; 0.184], P=0.031). Equation: y=0.01x+5.85, effect
size: 0.01, 95% CI=[0.00; 0.02]. MFC, muscle fat content; BMI, body mass index; SDS,
standard deviation score; VAT, visceral adipose tissue volume; SAT, subcutaneous adipose
tissue volume.[Pediatric Reports 2012; 4:e11] [page 41]
that the EMCL accumulates more readily than
the IMCL.
An association between MRS-assessed mus-
cular fat deposition and BMI has been reported
in two smaller studies on children and adoles-
cents (n=22 and n=29, respectively).19,20 We
also found an association between MFC and
BMI SDS in this larger group of obese children
and youths. However, we used BMI SDS as a
measure of obesity that also takes into account
the growth and development in boys and girls.
Glycolytic muscles generally contain less fat
than  oxidative  muscles.21,22 In  the  present
study,  the  amount  of  fat  deposited  as  IMCL
measured in the mainly glycolytic psoas major
muscle  was  higher  than  that  reported  by
Bredella et al. for the mainly glycolytic tibialis
anterior  muscle  in  21  obese  adult  women
(mean  BMI  34  kg/m2)  assessed  by  MRS.23
Compared with studies in children and adoles-
cents, the IMCL was slightly higher in our study
than  that  measured  in  the  mainly  oxidative
soleus muscle in two groups, each comprising
14 obese youth with normal glucose tolerance
(mean BMI 35 kg/m2; age 11-15 years andmean
BMI  39  kg/m2;  BMI  SDS  2.54;  age  13.5
years),19,24and in 14 obese youth with impaired
glucose tolerance (mean BMI 37 kg/m2; BMI
SDS  2.48;  age  13  years).24 The  IMCL  in  the
present study was also higher than that report-
ed in studies of 17 and 20 lean adults23,25and in
eight lean adolescents.19 These findings sug-
gest that deposition of fat in skeletal muscle
tissue is not related to age, but is promoted by
the increased amount of lipids available in the
natural course of severe obesity, as indicated by
the high MFC in these young, severely obese
patients in the present study.
Sinha et al. found a significant association
between VAT and both IMCL and EMCL in 14
obese (mean BMI 35 kg/m2; age 11-15 years)
and eight lean children.19 Similarly, Saukkonen
et al. found increased IMCL and VAT in eight
obese children with impaired glucose tolerance
and 13 obese children with normal glucose tol-
erance (mean BMI 36 kg/m2; age 11-15 years
and BMI 35 kg/m2; age 11-15 years) compared
with eight non-obese siblings.20These relation-
ships are similar to the association between
MFC and VAT found in the present study, sug-
gesting  that  the  development  of  visceral  fat
depot and muscular fat content might not be
independent of each other. However, MFC was
not  associated  with  liver  enzyme  concentra-
tions in the present study, suggesting that fat
deposition in the muscle is independent of the
liver status.
Plasma  TG  concentration  correlated  posi-
tively with IMCL content, but not with EMCL
content, in a study of 14 obese (mean BMI 35
kg/m2; age 11-15 years) and eight lean chil-
dren.19 However,  we  could  not  confirm  this
association  between  TG  concentration  and
Article
Table 1. Baseline characteristics of all 159 obese children and youths with a muscle fat content <5% and ≥5%, respectively.
Total MFC <5% MFC ≥5% MFC <5% MFC ≥5%
(n=41) (n=118)
(n=159) (n=41) (n=118) P boys girls P boys girls P
N  159 41 118 0.54 20 21 51 67
(boys/girls) (71/88) (20/21) (51/67)
Age (years) 13.3 13.5 13.2 0.51 13.6 13.5 0.93 12.8 13.8 0.19
±2.9 ±2.6 ±3.0 ±2.3 ±3.0 ±2.5 ±3.3
BMI SDS 3.04 2.82 3.11 0.03 3.1 2.6 0.02 3.4 2.9 <0.0001
±0.6 ±0.7 ±0.5 ±0.8 ±0.6 ±0.5 ±0.5
MFC (%) 8.9 3.3 10.9 <0.0001 3.0 3.6 0.05 10.3 11.3 0.47
±7.0 ±1.1 ±7.2 ±1.1 ±1.1 ±6.1 ±8.0
IMCL (%) 2.6 1.4 3.1 <0.0001 2.53 2.3 0.67 2.6 2.6 0.56
±1.9 ±0.8 ±2.0 ±2.3 ±1.8 ±2.0 ±1.7
EMCL (%) 6.3 1.9 7.8 <0.0001 4.20 5.3 0.94 4.5 8.6 0.88
±6.0 ±0.9 ±6.3 ±3.37 ±3.8 ±3.7 ±7.7
EMCL/IMCL ratio 2.9 2.1 3.2 0.003 2.1 2.0 0.87 3.7 2.5 0.07
±2.6 ±1.7 ±2.8 ±1.6 ±1.9 ±3.7 ±1.4
VAT (cm3)* 89 83 94 0.04 88.5 67 0.06 98 91 0.16
(30-258) (36-186) (30-258) (47-186) (36-171) (30-258) (36-217)
SAT (cm3)* 310 285 319 0.12 298 283 0.47 311 343 0.77
(104-752) (104-647) (108-752) (108-570) (104-647) (125-628) (108-752)
SAT/VAT ratio* 3.4 3.8 3.3 0.41 3.35 3.9 0.26 3.7 3.4 0.05
(1.6-10.3) (1.6-9.7) (1.7-10.3) (2-5.9) (1.6-9.7) (1.7-10.3) (1.9-8.3)
Tanner ♂G* 22 1 0.67
(1-5) (1-4) (1-5)
Tanner ♂P* 21 2 0.94
(1-5) (1-4) (1-5)
Tanner ♀B* 33 2 0.22
(1-5) (1-5) (1-5)
Tanner ♀P* 33 2
(1-5) (1-5) (1-5) 0.17
PAS (hrs/week)* 1.0 1.5 1.0 0.47 1.13 0 0.87 1.0 1.75 0.04
(0.0-8.0) (0.0-7.0) (0.0-8.0) (0-4.5) (0-5.25) (0-8) (0-8)
PIS (hrs/week)* 24.5 10.5 28 0.08 21 24.5 0.92 28 24.5 0.16
(3.5-70) (3.5-70) (14-70) (7-49) (3.5-70) (3.5-70) (3.5-70)
Data are unadjusted mean±standard deviation. *Data are median (range). MFC, muscle fat content; BMI, body mass index; SDS, standard deviation score; IMCL, intramyocellular lipid content; EMCL, extramyocellu-
lar lipid content; VAT, visceral adipose tissue volume; SAT, subcutaneous adipose tissue volume; G, genitals; P, pubic hair; B, breast; PAS, physical activity score; PIS, physical inactivity score.[page 42] [Pediatric Reports 2012; 4:e11]
MFC, IMCL or EMCL contents even though we
included a large group of children. This finding
is intriguing and may suggest a great variabil-
ity in plasma TG concentration in children and
youths,  even  though  blood  samples  were
acquired in relative proximity to the initiation
of treatment. A confounding factor is the time
gap between blood samples and MR examina-
tions in the present study, which was a median
of 41 days in the present study. The MR exam-
ination was done after treatment initiation in
the majority of the patients (96 of 119), which
might tend to show a decreased MFC due to
obesity treatment, which may have biased the
relationships studied.
Although the role of puberty in accumula-
tion of IMCL and muscular fat is not fully deter-
mined,  one  study  has  shown  elevated  IMCL
content in 5 lean girls with premature adrenar-
che (mean BMI SDS 0.65; age 7.8 years) com-
pared with prepubertal controls,26 which may
suggest that the IMCL content is affected by
pubertal  development  per  se.  In  the  present
study  we  did  not  find  associations  between
pubertal stages and MFC or IMCL.
An association between physical activity and
IMCL has been reported in healthy, lean adult
males,27,28 but we did not confirm this associa-
tion in the present study. However, it is diffi-
cult to compare these studies directly because
of divergent methods, differences in exercise
and workload duration, and the fact that the
above-mentioned  studies27,28 included  only
healthy, lean adult males whereas the obese
children and youths in the present study may
have great difficulty in attaining a high inten-
sity of physical activity. Although the present
study did not show a significant association
between  PIS  and  MFC  (P=0.08),  the  data
might indicate a tendency that children and
youths  performing  high  levels  of  inactivity
exhibit a high MFC.
We  acknowledge  that  several  confounding
factors may have biased the results in the pres-
ent study. One limitation of our study was the
lack of a control group, which would have been
desirable for comparing the results in obese
patients  with  normal-weight  children  and
youths.  A  second  limitation  was  that  the
extremely  obese  (>130  kg)  were  excluded
from  investigation  because  they  could  not
enter the MR scanner; this precluded the most
extreme  obese  patients  from  examination,
even though they had the highest probability
of  having  a  high  MFC.  MFC  and  IMCL  are
dependent  of  many  factors,  such  as  diet,28
morning-to-evening changes in MFC,28 exer-
cise  duration,27,28 exercise  workload,27,28
pubertal  development,26 muscle  type,21,22,29
age,30 sex,31,32 and obesity.29,31 In the present
study,  we  did  not  record  dietary  details,
although the participants were given specific
individual guidelines about food groups to eat
or avoid as part of the obesity treatment proto-
col.15 These guidelines included the generally
recommended diet low in carbohydrates and
fat. The 5% limit in MFC was defined arbitrar-
ily because no studies have defined a widely
accepted  MFC  limit.  We  used  the  5%  limit
because ectopic fat deposition is thought to be
pathological and because this is similar to the
limit used in the characterization of liver fat.17
The MRS examinations were not conducted in
the fasting condition, which may have caused
minor variations in the degree of MFC depend-
ing on the diet and time since the last meal
consumed.  To  avoid  morning-to-evening
changes,  the  MRS  examinations  occurred
between the hours of 9 and 11 in the morning.
We had interview-reported approximate esti-
mates of the duration of physical activity and
inactivity, which makes the PAS and PIS rough
estimates.  Unfortunately,  we  did  not  record
physical activity and inactivity on a daily basis
or the exercise workload or intensity.
Finally, fat deposition in skeletal muscle is a
patchy disease as both IMCL and EMCL are dis-
tributed  inhomogeneously.33,34 Therefore,
some variation should be expected, depending
on  the  placement  of  the  spectroscopy  VOI,
which we did not adjust for by measuring sev-
eral positions in the psoas muscle at the same
time.  Instead,  measurements  by  MRS  were
made in the same muscle (psoas major) on
approximately the same anatomical site in all
participants. The present MRS data were not
corrected for the effect of transverse relaxation
time,35 but such adjustments have not tradi-
tionally  been  performed  in  previous  stud-
ies.28,33 However,  the  calculated  MFC%,
IMCL%, and EMCL% in the present study may
deviate somewhat from the objective values.
Correction  for  longitudinal  relaxation  time
was not necessary because of the long TR.
The strength of this study is the relatively
Article
Table 2. Blood values in 119 of the obese children and youths investigated with proton magnetic resonance spectroscopy and magnetic
resonance imaging.
Total MFC <5% MFC ≥5% MFC <5% MFC ≥5%
(n=35) (n=84)
(n=119) (n=35) (n=84) P Boys Girls P Boys Girls P
N (boys/girls) 119 35 84 17 18 39 45
(56/63) (17/18) (39/45)
Age (years) 13.0 13.5 12.9 0.56 13.4 13.4 0.83 12.5 13.3 0.19
±2.8 ±2.6 ±2.9 ±2.4 ±2.9 ±2.3 ±2.3
BMI SDS 3.0 2.89 3.06 0.17 3.1 2.7 0.04 3.4 2.8 <0.0001
±0.6 ±0.7 ±0.6 ±0.8 ±0.6 ±0.6 ±0.4
MFC% 8.4 3.3 10.5 <0.0001 2.9 3.6 0.08 9.7 11.2 0.39
±7.1 ±1.1 ±7.5 ±1.1 ±1.1 ±5.6 ±8.8
TG (mmol/l)* 1.1 1.1 1.1 0.80 1.1 1.1 0.82 0.85 1.2 0.06
(0.3-5.8) (0.3-3.2) (0.3-5.8) (0.3-3.2) (0.5-2) (0.3-5.8) (0.5-2.4)
GGT  17.0 16.5 17.0 0.81 20 15 0.02 16.5 17 0.78
(U/l)* (8-134) (8-134) (9-87) (13-134) (8-34) (9-87) (9-61)
ALT 25.0 14.0 25.0 0.68 30 21.5 0.04 25 24 0.50
(U/l)* (12-93) (14-91) (12-93) (16-91) (14-49) (13-93) (12-87)
LDH 220 218.0 220.0 0.56 232 183 0.02 235 200 0.0092
(U/l)* (112-321) (123-281) (112-321) (170-271) (123-281) (112-321) (115-297)
AP 230 230.5 230.0 0.64 255 153 0.003 258 194 0.0017
(U/l)* (50-432) (50-432) (67-396) (115-432) (50-307) (88-396) (67-389)
Data are unadjusted mean±standard deviation. *Data are median (range). MRS, proton magnetic resonance spectroscopy; MRI, magnetic resonance imaging; BMI, body mass index; SDS, standard deviation score;
MFC, muscle fat content; TG, triglyceride; GGT, gamma-glutamyl transferase; ALT, alanine transaminase; LDH, lactate dehydrogenase; AP, alkaline phosphatase.[Pediatric Reports 2012; 4:e11] [page 43]
large number of participants investigated using
a non-invasive, non-ionizing, and precise tech-
nology, which showed that most of the patients
had increased fat content in their muscles.
Conclusion
Most obese children and youths are prone to
having  elevated  MFC,  which  is  reflected  by
increased  fat  deposition  in  the  intra-  and
extramyocellular  lipid  compartments  and  is
associated with an elevated VAT. Mounting evi-
dence links general obesity and elevated mus-
cular fat and visceral adipose tissue volume to
an increased metabolic risk profile.19,20,24,36,37
It  is  important  to  identify  and  monitor  the
development  of  MFC  from  an  early  age  in
obese children.
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